Finding 400912 (2022-004)

Material Weakness
Requirement
P
Questioned Costs
-
Year
2022
Accepted
2024-06-14

AI Summary

  • Core Issue: The Clinic lacks an effective internal control system for preparing the schedule of expenditures of federal awards.
  • Impacted Requirements: Compliance with financial reporting standards is compromised, as proper controls are essential for accurate reporting.
  • Recommended Follow-Up: Management should stay informed about financial reporting requirements and enhance internal controls related to federal award expenditures.

Finding Text

Department of Health and Human Services Federal Assistance Listing #93.498 COVID‐19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year – Period 2 TIN#4550559322 Department of Homeland Security Federal Assistance Listing #97.036 COVID‐19 Disaster Grants – Public Assistance Preparation of Schedule of Expenditures of Federal Awards Material Weakness in Internal Control over Compliance ‐ Other Criteria: Proper controls over financial reporting include a system designed to prepare the schedule of expenditures of federal awards and accompanying notes to the schedule of expenditures of federal awards. Condition: The Clinic does not have an internal control system designed to provide for the preparation of the schedule of expenditures of federal. As auditors, we were requested to draft the schedule of expenditures of federal awards. Cause: Auditor assistance with preparation of the schedule is not unusual as the schedule has unique and specialized requirements and preparation is only required when the Clinic meets a specified threshold of federal expenditures. Effect: There is a reasonable possibility that the Clinic would not be able to draft a complete and accurate schedule of expenditures of federal awards without the assistance of the auditors. Questioned Costs: None reported. Context: Sampling was not used. Repeat Finding from Prior Years: No Recommendation: We recommend management continually be aware of the financial reporting requirements relating to the Clinic’s schedule of expenditures of federal awards and the internal controls that impact financial reporting. View of Responsible Officials: Management agrees with the finding.

Categories

Reporting Material Weakness

Other Findings in this Audit

  • 400902 2022-004
    Material Weakness
  • 400903 2022-005
    Material Weakness
  • 400904 2022-004
    Material Weakness
  • 400905 2022-006
    Material Weakness
  • 400906 2022-004
    Material Weakness
  • 400907 2022-006
    Material Weakness
  • 400908 2022-004
    Material Weakness
  • 400909 2022-006
    Material Weakness
  • 400910 2022-004
    Material Weakness
  • 400911 2022-006
    Material Weakness
  • 400913 2022-006
    Material Weakness
  • 977344 2022-004
    Material Weakness
  • 977345 2022-005
    Material Weakness
  • 977346 2022-004
    Material Weakness
  • 977347 2022-006
    Material Weakness
  • 977348 2022-004
    Material Weakness
  • 977349 2022-006
    Material Weakness
  • 977350 2022-004
    Material Weakness
  • 977351 2022-006
    Material Weakness
  • 977352 2022-004
    Material Weakness
  • 977353 2022-006
    Material Weakness
  • 977354 2022-004
    Material Weakness
  • 977355 2022-006
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $360,804
93.697 Covid-19 Testing for Rural Health Clinics $200,000
93.498 Provider Relief Fund $157,739
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $99,058
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $82,851